Industry Update: Pharmaceuticals

Industry Highlights

  • On December 28, 2021, Novo Nordisk completed the acquisition of Dicerna Pharmaceuticals, Inc. for approximately $3.2 billion. Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals.
  • On December 16, 2021, Allergan Aesthetics, an AbbVie company, announced the successful completion of its acquisition of Soliton, Inc. for approximately $580 million. The addition of Soliton and its technology complements Allergan Aesthetics’ portfolio of non-invasive body contouring treatments to now include a proven treatment for the appearance of cellulite.

Past Industry Updates

Pharmaceuticals: July 2021

Pharmaceuticals: May 2021

Pharmaceuticals: January 2021

Pharmaceuticals: October 2020

Pharmaceuticals: July 2020

Pharmaceuticals: May 2020

Pharmaceuticals: December 2019

Pharmaceuticals: October 2019

More Industry Reports